Navigation Links
US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
Date:7/11/2012

BELLEVUE, Wash., July 11, 2012 /PRNewswire/ -- Summit Associates International today announced that it was awarded US Patent 8,183,204, on methods and compositions for increasing skin remodeling. The patent describes the use of metal peptides for helping to diminish or remove various skin imperfections, including wound and surgical scars, acne scars, keloids, skin tags, benign skin moles, stretch marks, facial keratosis, sunspots, or a vitiligo.

The inventor, Dr. Loren Pickart, previously discovered the human skin-remodeling, copper-binding peptide GHK, and then developed clinically-proven methods for its use in cosmetic skin improvement, hair growth, and hair transplantation. Recent published work from numerous universities found that GHK controls or heavily influences 17% of the human genome, and also possesses a multiplicity of "wellness" properties including regeneration of tissues, activation of quiescent stem cells, suppression of numerous cancer metastasis genes, plus anti-inflammatory and anti-infection actions.

"The real cause of aging and most diseases is the silencing of regenerative and protective genes," said Dr. Pickart, "At age 25, our genes produce the healthiest mix of proteins, then gene silencing reduces the effect of our regenerative genes and increases the influence inflammatory and cancer-promoting genes. Summit Associates is also focused on developing and patenting methods of re-programming the human gene pattern to inhibit cancer growth and the effects of human senescence."

Summit Associates is Dr. Pickart's research group and located in Bellevue, WA. More information can be found at www.summit-associates-intl.com


Media contact:
Dr. Loren Pickart
425-644-0160
Email lorenpickart@summit-associate-intl.com


'/>"/>
SOURCE Summit Associates International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Enbrel® (etanercept) Patent Issued
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
6. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
7. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
8. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
9. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017 For today, Stock-Callers.com redirects investors, ... development and clinical research aimed at treating diseases and medical ... Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), ... can access our complimentary research reports on these stocks now ... http://stock-callers.com/registration ...
(Date:4/19/2017)... ... 2017 , ... A number of new instruments have recently emerged to accommodate ... Protein and Cell Analysis Education Webinar Series , will focus on advances in ... and future applications. , Many flow cytometers have unique capabilities and the Attune ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced ... comes after the company changed focus to making analytical tools for biopharmaceutical quality ... new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the PCR Improvement ... adds to several other early achievements at ThermaGenix, including the business formation and ... , ThermaGenix will use proceeds from the Series A-1 round to:, ...
Breaking Biology Technology:
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):